Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Lapatinib | 1 | uM | 9 | 625.00 | 414.82 | 450.00 | 785.00 | 0.5733 | 0.0925 |
| SK-BR-3 | Lapatinib | 10 | uM | 9 | 625.00 | 414.82 | 304.00 | 785.00 | 0.3873 | -0.2866 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 9 | 625.00 | 414.82 | 834.00 | 785.00 | 1.0624 | 1.1360 |
| SK-BR-3 | Linsitinib | 0.1 | uM | 9 | 625.00 | 414.82 | 922.00 | 785.00 | 1.1745 | 1.3820 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 9 | 625.00 | 414.82 | 620.00 | 785.00 | 0.7898 | 0.5476 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 9 | 625.00 | 414.82 | 378.00 | 785.00 | 0.4815 | -0.0961 |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 786.00 | 785.00 | 1.0013 | 1.0028 | |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 2004.00 | 1997.25 | 1.0034 | 1.0053 | |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 2017.00 | 1997.25 | 1.0099 | 1.0156 | |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 9 | 1250.00 | 830.55 | 1749.00 | 1997.25 | 0.8757 | 0.8009 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 9 | 1250.00 | 830.55 | 1702.00 | 1997.25 | 0.8522 | 0.7626 |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 9 | 1250.00 | 830.55 | 1986.00 | 1997.25 | 0.9944 | 0.9911 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 9 | 1250.00 | 830.55 | 1509.00 | 1997.25 | 0.7555 | 0.6027 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 9 | 1250.00 | 830.55 | 1058.00 | 1997.25 | 0.5297 | 0.2107 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 9 | 1250.00 | 830.55 | 1276.00 | 1997.25 | 0.6389 | 0.4038 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 9 | 1250.00 | 830.55 | 2156.00 | 1997.25 | 1.0795 | 1.1246 |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 2139.00 | 1997.25 | 1.0710 | 1.1113 | |
| SK-BR-3 | 17-AAG | 0.1 | uM | 9 | 1250.00 | 830.55 | 933.00 | 1997.25 | 0.4671 | 0.0962 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 9 | 1250.00 | 830.55 | 2303.00 | 1997.25 | 1.1531 | 1.2382 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 9 | 1250.00 | 830.55 | 1011.00 | 1997.25 | 0.5062 | 0.1680 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 9 | 1250.00 | 830.55 | 1830.00 | 1997.25 | 0.9163 | 0.8665 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 9 | 1250.00 | 830.55 | 1775.00 | 1997.25 | 0.8887 | 0.8220 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 9 | 1250.00 | 830.55 | 2357.00 | 1997.25 | 1.1801 | 1.2796 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 9 | 1250.00 | 830.55 | 2087.00 | 1997.25 | 1.0449 | 1.0707 |
| SK-BR-3 | Erlotinib | 1 | uM | 9 | 1250.00 | 830.55 | 1921.00 | 1997.25 | 0.9618 | 0.9394 |